{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:17:09Z","timestamp":1767212229804,"version":"3.37.3"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2020MC020","ZR2020MH302"],"award-info":[{"award-number":["ZR2020MC020","ZR2020MH302"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11262-022-01940-6","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T09:02:48Z","timestamp":1665824568000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The lytic phase of Epstein\u2013Barr virus plays an important role in tumorigenesis"],"prefix":"10.1007","volume":"59","author":[{"given":"Yue","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"key":"1940_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/21645515.2018.1543525","volume":"15","author":"S Bedri","year":"2019","unstructured":"Bedri S, Sultan AA, Alkhalaf M, Al-moustafa AE, Vranic S (2019) Epstein-Barr virus (EBV) status in colorectal cancer: a mini review. Hum Vaccines Immunother 15:603\u2013610. https:\/\/doi.org\/10.1080\/21645515.2018.1543525","journal-title":"Hum Vaccines Immunother"},{"key":"1940_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-981-10-7230-7_18","volume":"1045","author":"T Murata","year":"2018","unstructured":"Murata T (2018) Encyclopedia of EBV-encoded lytic genes: an update. Adv Exp Med Biol 1045:395\u2013412. https:\/\/doi.org\/10.1007\/978-981-10-7230-7_18","journal-title":"Adv Exp Med Biol"},{"key":"1940_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/v13122344","author":"T Murata","year":"2021","unstructured":"Murata T et al (2021) Molecular basis of epstein-barr virus latency establishment and lytic reactivation. Viruses. https:\/\/doi.org\/10.3390\/v13122344","journal-title":"Viruses"},{"key":"1940_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-319-22822-8_8","volume":"390","author":"DA Thorley-Lawson","year":"2015","unstructured":"Thorley-Lawson DA (2015) EBV persistence-introducing the virus. Curr Top Microbiol Immunol 390:151\u2013209. https:\/\/doi.org\/10.1007\/978-3-319-22822-8_8","journal-title":"Curr Top Microbiol Immunol"},{"key":"1940_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-319-22834-1_6","volume":"391","author":"RL Skalsky","year":"2015","unstructured":"Skalsky RL, Cullen BR (2015) EBV noncoding RNAs. Curr Top Microbiol Immunol 391:181\u2013217. https:\/\/doi.org\/10.1007\/978-3-319-22834-1_6","journal-title":"Curr Top Microbiol Immunol"},{"key":"1940_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/375685a0","volume":"375","author":"J Levitskaya","year":"1995","unstructured":"Levitskaya J et al (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685\u2013688. https:\/\/doi.org\/10.1038\/375685a0","journal-title":"Nature"},{"key":"1940_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.semcancer.2008.10.004","volume":"18","author":"JM Middeldorp","year":"2008","unstructured":"Middeldorp JM, Pegtel DM (2008) Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin Cancer Biol 18:388\u2013396. https:\/\/doi.org\/10.1016\/j.semcancer.2008.10.004","journal-title":"Semin Cancer Biol"},{"key":"1940_CR8","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1182\/blood-2014-08-594689","volume":"125","author":"JH Lin","year":"2015","unstructured":"Lin JH et al (2015) Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1. Blood 125:2228\u20132238. https:\/\/doi.org\/10.1182\/blood-2014-08-594689","journal-title":"Blood"},{"key":"1940_CR9","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1128\/mcb.14.5.3041-3052.1994","volume":"14","author":"EK Flemington","year":"1994","unstructured":"Flemington EK, Lytle JP, Cayrol C, Borras AM, Speck SH (1994) DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities. Mol Cell Biol 14:3041\u20133052. https:\/\/doi.org\/10.1128\/mcb.14.5.3041-3052.1994","journal-title":"Mol Cell Biol"},{"key":"1940_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","volume":"26","author":"SC Kenney","year":"2014","unstructured":"Kenney SC, Mertz JE (2014) Regulation of the latent-lytic switch in Epstein-Barr virus. Semin Cancer Biol 26:60\u201368. https:\/\/doi.org\/10.1016\/j.semcancer.2014.01.002","journal-title":"Semin Cancer Biol"},{"key":"1940_CR11","doi-asserted-by":"publisher","first-page":"9027","DOI":"10.1128\/jvi.00721-14","volume":"88","author":"YJ Jung","year":"2014","unstructured":"Jung YJ, Choi H, Kim H, Lee SK (2014) MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1. J Virol 88:9027\u20139037. https:\/\/doi.org\/10.1128\/jvi.00721-14","journal-title":"J Virol"},{"key":"1940_CR12","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1128\/jvi.72.5.4015-4021.1998","volume":"72","author":"LD Strockbine","year":"1998","unstructured":"Strockbine LD et al (1998) The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol 72:4015\u20134021. https:\/\/doi.org\/10.1128\/jvi.72.5.4015-4021.1998","journal-title":"J Virol"},{"key":"1940_CR13","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1101\/gad.1012702","volume":"16","author":"A Cuconati","year":"2002","unstructured":"Cuconati A, White E (2002) Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev 16:2465\u20132478. https:\/\/doi.org\/10.1101\/gad.1012702","journal-title":"Genes Dev"},{"key":"1940_CR14","doi-asserted-by":"publisher","first-page":"10110","DOI":"10.1128\/jvi.01110-15","volume":"89","author":"MJ Strong","year":"2015","unstructured":"Strong MJ et al (2015) Latent expression of the Epstein-Barr virus (EBV)-encoded major histocompatibility complex class I TAP inhibitor, BNLF2a EBV-Positive Gastric Carcinomas. J Virol 89:10110\u201310114. https:\/\/doi.org\/10.1128\/jvi.01110-15","journal-title":"J Virol"},{"key":"1940_CR15","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1128\/jvi.00063-14","volume":"88","author":"SH Chiu","year":"2014","unstructured":"Chiu SH et al (2014) Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle. J Virol 88:4962\u20134975. https:\/\/doi.org\/10.1128\/jvi.00063-14","journal-title":"J Virol"},{"key":"1940_CR16","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1128\/jvi.79.1.536-546.2005","volume":"79","author":"SJ Paulsen","year":"2005","unstructured":"Paulsen SJ, Rosenkilde MM, Eugen-Olsen J, Kledal TN (2005) Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. J Virol 79:536\u2013546. https:\/\/doi.org\/10.1128\/jvi.79.1.536-546.2005","journal-title":"J Virol"},{"key":"1940_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1006\/viro.1995.1235","volume":"209","author":"MG Kurilla","year":"1995","unstructured":"Kurilla MG, Heineman T, Davenport LC, Kieff E, Hutt-Fletcher LM (1995) A novel Epstein-Barr virus glycoprotein gp150 expressed from the BDLF3 open reading frame. Virology 209:108\u2013121. https:\/\/doi.org\/10.1006\/viro.1995.1235","journal-title":"Virology"},{"key":"1940_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/rmv.441","volume":"15","author":"T Tsurumi","year":"2005","unstructured":"Tsurumi T, Fujita M, Kudoh A (2005) Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15:3\u201315. https:\/\/doi.org\/10.1002\/rmv.441","journal-title":"Rev Med Virol"},{"key":"1940_CR19","doi-asserted-by":"publisher","first-page":"7654","DOI":"10.1128\/jvi.67.12.7654-7658.1993","volume":"67","author":"M Kawanishi","year":"1993","unstructured":"Kawanishi M (1993) Epstein-Barr virus induces fragmentation of chromosomal DNA during lytic infection. J Virol 67:7654\u20137658. https:\/\/doi.org\/10.1128\/jvi.67.12.7654-7658.1993","journal-title":"J Virol"},{"key":"1940_CR20","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1128\/jvi.75.5.2400-2410.2001","volume":"75","author":"GJ Inman","year":"2001","unstructured":"Inman GJ, Binn\u00e9 UK, Parker GA, Farrell PJ, Allday MJ (2001) Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death. J Virol 75:2400\u20132410. https:\/\/doi.org\/10.1128\/jvi.75.5.2400-2410.2001","journal-title":"J Virol"},{"key":"1940_CR21","first-page":"549","volume":"10","author":"DS Huen","year":"1995","unstructured":"Huen DS, Henderson SA, Croom-Carter D, Rowe M (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549\u2013560","journal-title":"Oncogene"},{"key":"1940_CR22","doi-asserted-by":"publisher","first-page":"24157","DOI":"10.1016\/S0021-9258(18)35741-7","volume":"267","author":"CD Laherty","year":"1992","unstructured":"Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM (1992) The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem 267:24157\u201324160","journal-title":"J Biol Chem"},{"key":"1940_CR23","doi-asserted-by":"publisher","first-page":"19533","DOI":"10.1038\/srep19533","volume":"6","author":"MA Morris","year":"2016","unstructured":"Morris MA et al (2016) The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A\/TGF\u03b2 and \u03b21 integrin signalling. Sci Rep 6:19533. https:\/\/doi.org\/10.1038\/srep19533","journal-title":"Sci Rep"},{"key":"1940_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/sj.onc.1209023","volume":"25","author":"NJ Thornburg","year":"2006","unstructured":"Thornburg NJ et al (2006) LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene 25:288\u2013297. https:\/\/doi.org\/10.1038\/sj.onc.1209023","journal-title":"Oncogene"},{"key":"1940_CR25","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1128\/jvi.01888-07","volume":"82","author":"CW Dawson","year":"2008","unstructured":"Dawson CW, Laverick L, Morris MA, Tramoutanis G, Young LS (2008) Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol 82:3654\u20133664. https:\/\/doi.org\/10.1128\/jvi.01888-07","journal-title":"J Virol"},{"key":"1940_CR26","first-page":"185","volume":"4","author":"H Zheng","year":"2007","unstructured":"Zheng H, Li LL, Hu DS, Deng XY, Cao Y (2007) Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol 4:185\u2013196","journal-title":"Cell Mol Immunol"},{"key":"1940_CR27","first-page":"128","volume":"3","author":"CL Miller","year":"1994","unstructured":"Miller CL et al (1994) Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction. Infect Agents Dis 3:128\u2013136","journal-title":"Infect Agents Dis"},{"key":"1940_CR28","doi-asserted-by":"publisher","first-page":"8619","DOI":"10.1038\/sj.onc.1207905","volume":"23","author":"T Portis","year":"2004","unstructured":"Portis T, Longnecker R (2004) Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras\/PI3K\/Akt pathway. Oncogene 23:8619\u20138628. https:\/\/doi.org\/10.1038\/sj.onc.1207905","journal-title":"Oncogene"},{"key":"1940_CR29","doi-asserted-by":"publisher","first-page":"9556","DOI":"10.1128\/jvi.76.18.9556-9561.2002","volume":"76","author":"SY Chen","year":"2002","unstructured":"Chen SY, Lu J, Shih YC, Tsai CH (2002) Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J Virol 76:9556\u20139561. https:\/\/doi.org\/10.1128\/jvi.76.18.9556-9561.2002","journal-title":"J Virol"},{"key":"1940_CR30","doi-asserted-by":"publisher","first-page":"12276","DOI":"10.1128\/jvi.77.22.12276-12284.2003","volume":"77","author":"JA Morrison","year":"2003","unstructured":"Morrison JA, Klingelhutz AJ, Raab-Traub N (2003) Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J Virol 77:12276\u201312284. https:\/\/doi.org\/10.1128\/jvi.77.22.12276-12284.2003","journal-title":"J Virol"},{"key":"1940_CR31","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1093\/nar\/gkv212","volume":"43","author":"S Ramasubramanyan","year":"2015","unstructured":"Ramasubramanyan S et al (2015) Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression. Nucleic Acids Res 43:3563\u20133577. https:\/\/doi.org\/10.1093\/nar\/gkv212","journal-title":"Nucleic Acids Res"},{"key":"1940_CR32","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1128\/jvi.69.7.4206-4212.1995","volume":"69","author":"C Cayrol","year":"1995","unstructured":"Cayrol C, Flemington EK (1995) Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1. J Virol 69:4206\u20134212. https:\/\/doi.org\/10.1128\/jvi.69.7.4206-4212.1995","journal-title":"J Virol"},{"key":"1940_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/1743-422x-8-422","volume":"8","author":"DH Dreyfus","year":"2011","unstructured":"Dreyfus DH, Liu Y, Ghoda LY, Chang JT (2011) Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-\u03baB and p53. Virology journal 8:422. https:\/\/doi.org\/10.1186\/1743-422x-8-422","journal-title":"Virology journal"},{"key":"1940_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061479","author":"D Germini","year":"2020","unstructured":"Germini D et al (2020) Oncogenic properties of the EBV ZEBRA protein. Cancers. https:\/\/doi.org\/10.3390\/cancers12061479","journal-title":"Cancers"},{"key":"1940_CR35","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.7150\/ijbs.16564","volume":"12","author":"H Li","year":"2016","unstructured":"Li H et al (2016) Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis. Int J Biol Sci 12:1309\u20131318. https:\/\/doi.org\/10.7150\/ijbs.16564","journal-title":"Int J Biol Sci"},{"key":"1940_CR36","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.4049\/jimmunol.1002656","volume":"186","author":"D Horst","year":"2011","unstructured":"Horst D et al (2011) EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP. J Immunol 186:3594\u20133605. https:\/\/doi.org\/10.4049\/jimmunol.1002656","journal-title":"J Immunol"},{"key":"1940_CR37","doi-asserted-by":"publisher","first-page":"41402","DOI":"10.1074\/jbc.M111.237784","volume":"286","author":"AI Wycisk","year":"2011","unstructured":"Wycisk AI et al (2011) Epstein-Barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP. J Biol Chem 286:41402\u201341412. https:\/\/doi.org\/10.1074\/jbc.M111.237784","journal-title":"J Biol Chem"},{"key":"1940_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000490","volume":"5","author":"NP Croft","year":"2009","unstructured":"Croft NP et al (2009) Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle. PLoS Pathog 5:e1000490. https:\/\/doi.org\/10.1371\/journal.ppat.1000490","journal-title":"PLoS Pathog"},{"key":"1940_CR39","doi-asserted-by":"publisher","first-page":"10515","DOI":"10.1128\/jvi.00955-13","volume":"87","author":"MS Chang","year":"2013","unstructured":"Chang MS et al (2013) Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-\u03baB. J Virol 87:10515\u201310523. https:\/\/doi.org\/10.1128\/jvi.00955-13","journal-title":"J Virol"},{"key":"1940_CR40","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.3892\/ol.2018.8293","volume":"15","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Xu M, Zhang X, Chu F, Zhou T (2018) MAPK\/c-Jun signaling pathway contributes to the upregulation of the anti-apoptotic proteins Bcl-2 and Bcl-xL induced by Epstein-Barr virus-encoded BARF1 in gastric carcinoma cells. Oncol Lett 15:7537\u20137544. https:\/\/doi.org\/10.3892\/ol.2018.8293","journal-title":"Oncol Lett"},{"key":"1940_CR41","doi-asserted-by":"publisher","first-page":"775","DOI":"10.5152\/tjg.2020.18827","volume":"31","author":"S Li","year":"2020","unstructured":"Li S et al (2020) The role of the Epstein-Barr virus-encoded BARF1 gene expressed in human gastric epithelial cells. Turkish J Gastroenterol 31:775\u2013781. https:\/\/doi.org\/10.5152\/tjg.2020.18827","journal-title":"Turkish J Gastroenterol"},{"key":"1940_CR42","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1593\/neo.09706","volume":"11","author":"R Jiang","year":"2009","unstructured":"Jiang R, Cabras G, Sheng W, Zeng Y, Ooka T (2009) Synergism of BARF1 with Ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells. Neoplasia (New York, N.Y.) 11:964\u2013973. https:\/\/doi.org\/10.1593\/neo.09706","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"1940_CR43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.mib.2010.05.007","volume":"13","author":"K Brennan","year":"2010","unstructured":"Brennan K, Bowie AG (2010) Activation of host pattern recognition receptors by viruses. Curr Opin Microbiol 13:503\u2013507. https:\/\/doi.org\/10.1016\/j.mib.2010.05.007","journal-title":"Curr Opin Microbiol"},{"key":"1940_CR44","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1128\/jvi.00805-13","volume":"87","author":"MA Ansari","year":"2013","unstructured":"Ansari MA et al (2013) Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells. J Virol 87:8606\u20138623. https:\/\/doi.org\/10.1128\/jvi.00805-13","journal-title":"J Virol"},{"key":"1940_CR45","doi-asserted-by":"publisher","first-page":"e50714","DOI":"10.15252\/embr.202050714","volume":"22","author":"X Long","year":"2021","unstructured":"Long X et al (2021) BRLF1 suppresses RNA Pol III-mediated RIG-I inflammasome activation in the early EBV lytic lifecycle. EMBO Rep 22:e50714. https:\/\/doi.org\/10.15252\/embr.202050714","journal-title":"EMBO Rep"},{"key":"1940_CR46","doi-asserted-by":"publisher","first-page":"e1002704","DOI":"10.1371\/journal.ppat.1002704","volume":"8","author":"S Jochum","year":"2012","unstructured":"Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R (2012) The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination. PLoS Pathog 8:e1002704. https:\/\/doi.org\/10.1371\/journal.ppat.1002704","journal-title":"PLoS Pathog"},{"key":"1940_CR47","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1099\/jgv.0.001056","volume":"99","author":"R Almohammed","year":"2018","unstructured":"Almohammed R et al (2018) Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta. J Gen Virol 99:805\u2013817. https:\/\/doi.org\/10.1099\/jgv.0.001056","journal-title":"J Gen Virol"},{"key":"1940_CR48","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1073\/pnas.0611128104","volume":"104","author":"M Rowe","year":"2007","unstructured":"Rowe M et al (2007) Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci USA 104:3366\u20133371. https:\/\/doi.org\/10.1073\/pnas.0611128104","journal-title":"Proc Natl Acad Sci USA"},{"key":"1940_CR49","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1128\/jvi.01608-10","volume":"85","author":"J Zuo","year":"2011","unstructured":"Zuo J et al (2011) The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways. J Virol 85:1604\u20131614. https:\/\/doi.org\/10.1128\/jvi.01608-10","journal-title":"J Virol"},{"key":"1940_CR50","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1128\/jvi.02183-15","volume":"90","author":"LL Quinn","year":"2016","unstructured":"Quinn LL et al (2016) The missing link in Epstein-Barr virus immune evasion: the BDLF3 gene induces ubiquitination and downregulation of major histocompatibility complex class I (MHC-I) and MHC-II. J Virol 90:356\u2013367. https:\/\/doi.org\/10.1128\/jvi.02183-15","journal-title":"J Virol"},{"key":"1940_CR51","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/ijc.22839","volume":"121","author":"RJ Jones","year":"2007","unstructured":"Jones RJ et al (2007) Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Int J Cancer 121:1274\u20131281. https:\/\/doi.org\/10.1002\/ijc.22839","journal-title":"Int J Cancer"},{"key":"1940_CR52","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/jmv.23208","volume":"84","author":"KR Katsumura","year":"2012","unstructured":"Katsumura KR, Maruo S, Takada K (2012) EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes. J Med Virol 84:504\u2013510. https:\/\/doi.org\/10.1002\/jmv.23208","journal-title":"J Med Virol"},{"key":"1940_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1182\/blood-2008-12-193375","volume":"114","author":"SC Tsai","year":"2009","unstructured":"Tsai SC et al (2009) EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines. Blood 114:109\u2013118. https:\/\/doi.org\/10.1182\/blood-2008-12-193375","journal-title":"Blood"},{"key":"1940_CR54","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1128\/jvi.02301-07","volume":"82","author":"M Hsu","year":"2008","unstructured":"Hsu M et al (2008) Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells. J Virol 82:3679\u20133688. https:\/\/doi.org\/10.1128\/jvi.02301-07","journal-title":"J Virol"},{"key":"1940_CR55","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1128\/jvi.00182-11","volume":"85","author":"CH Lee","year":"2011","unstructured":"Lee CH et al (2011) Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytes. J Virol 85:7333\u20137342. https:\/\/doi.org\/10.1128\/jvi.00182-11","journal-title":"J Virol"},{"key":"1940_CR56","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1007\/s10616-016-9987-9","volume":"68","author":"YX Ren","year":"2016","unstructured":"Ren YX et al (2016) Viral IL-10 down-regulates the \u201cMHC-I antigen processing operon\u201d through the NF-\u03baB signaling pathway in nasopharyngeal carcinoma cells. Cytotechnology 68:2625\u20132636. https:\/\/doi.org\/10.1007\/s10616-016-9987-9","journal-title":"Cytotechnology"},{"key":"1940_CR57","doi-asserted-by":"publisher","first-page":"13984","DOI":"10.1128\/jvi.79.22.13984-13992.2005","volume":"79","author":"GK Hong","year":"2005","unstructured":"Hong GK et al (2005) Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines. J Virol 79:13984\u201313992. https:\/\/doi.org\/10.1128\/jvi.79.22.13984-13992.2005","journal-title":"J Virol"},{"key":"1940_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010146","author":"S Niland","year":"2021","unstructured":"Niland S, Riscanevo AX, Eble JA (2021) Matrix metalloproteinases shape the tumor microenvironment in cancer progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23010146","journal-title":"Int J Mol Sci"},{"key":"1940_CR59","doi-asserted-by":"publisher","first-page":"e56121","DOI":"10.1371\/journal.pone.0056121","volume":"8","author":"YY Lan","year":"2013","unstructured":"Lan YY et al (2013) Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro. PLoS ONE 8:e56121. https:\/\/doi.org\/10.1371\/journal.pone.0056121","journal-title":"PLoS ONE"},{"key":"1940_CR60","first-page":"256","volume":"63","author":"J Lu","year":"2003","unstructured":"Lu J, Chua HH, Chen SY, Chen JY, Tsai CH (2003) Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. Can Res 63:256\u2013262","journal-title":"Can Res"},{"key":"1940_CR61","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.2174\/138161206779010495","volume":"12","author":"S Rodriguez-Nieto","year":"2006","unstructured":"Rodriguez-Nieto S, Zhivotovsky B (2006) Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. Curr Pharm Des 12:4411\u20134425. https:\/\/doi.org\/10.2174\/138161206779010495","journal-title":"Curr Pharm Des"},{"key":"1940_CR62","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/emboj.2011.307","volume":"30","author":"A Strasser","year":"2011","unstructured":"Strasser A, Cory S, Adams JM (2011) Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 30:3667\u20133683. https:\/\/doi.org\/10.1038\/emboj.2011.307","journal-title":"EMBO J"},{"key":"1940_CR63","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/s41418-019-0435-1","volume":"27","author":"L Fitzsimmons","year":"2020","unstructured":"Fitzsimmons L et al (2020) EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins. Cell Death Differ 27:1554\u20131568. https:\/\/doi.org\/10.1038\/s41418-019-0435-1","journal-title":"Cell Death Differ"},{"key":"1940_CR64","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.virusres.2011.12.017","volume":"163","author":"WL Hsu","year":"2012","unstructured":"Hsu WL, Chung PJ, Tsai MH, Chang CL, Liang CL (2012) A role for Epstein-Barr viral BALF1 in facilitating tumor formation and metastasis potential. Virus Res 163:617\u2013627. https:\/\/doi.org\/10.1016\/j.virusres.2011.12.017","journal-title":"Virus Res"},{"key":"1940_CR65","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1128\/jvi.73.6.5181-5185.1999","volume":"73","author":"WL Marshall","year":"1999","unstructured":"Marshall WL et al (1999) Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol 73:5181\u20135185. https:\/\/doi.org\/10.1128\/jvi.73.6.5181-5185.1999","journal-title":"J Virol"},{"key":"1940_CR66","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.molimm.2010.02.017","volume":"47","author":"Q Guo","year":"2010","unstructured":"Guo Q et al (2010) Transactivators Zta and Rta of Epstein-Barr virus promote G0\/G1 to S transition in Raji cells: a novel relationship between lytic virus and cell cycle. Mol Immunol 47:1783\u20131792. https:\/\/doi.org\/10.1016\/j.molimm.2010.02.017","journal-title":"Mol Immunol"},{"key":"1940_CR67","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1128\/jvi.75.10.4482-4489.2001","volume":"75","author":"A Rodriguez","year":"2001","unstructured":"Rodriguez A, Jung EJ, Flemington EK (2001) Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents. J Virol 75:4482\u20134489. https:\/\/doi.org\/10.1128\/jvi.75.10.4482-4489.2001","journal-title":"J Virol"},{"key":"1940_CR68","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.1128\/jvi.73.8.6540-6550.1999","volume":"73","author":"JJ Swenson","year":"1999","unstructured":"Swenson JJ, Mauser AE, Kaufmann WK, Kenney SC (1999) The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J Virol 73:6540\u20136550. https:\/\/doi.org\/10.1128\/jvi.73.8.6540-6550.1999","journal-title":"J Virol"},{"key":"1940_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1099\/vir.0.034405-0","volume":"93","author":"SY Huang","year":"2012","unstructured":"Huang SY et al (2012) Epstein-Barr virus Rta-mediated transactivation of p21 and 14\u20133-3\u03c3 arrests cells at the G1\/S transition by reducing cyclin E\/CDK2 activity. J Gen Virol 93:139\u2013149. https:\/\/doi.org\/10.1099\/vir.0.034405-0","journal-title":"J Gen Virol"},{"key":"1940_CR70","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00736-17","author":"YJ Chen","year":"2017","unstructured":"Chen YJ et al (2017) Epstein-Barr virus Rta-mediated accumulation of DNA methylation interferes with CTCF binding in both host and viral genomes. J Virol. https:\/\/doi.org\/10.1128\/jvi.00736-17","journal-title":"J Virol"},{"key":"1940_CR71","doi-asserted-by":"publisher","first-page":"14257","DOI":"10.1038\/ncomms14257","volume":"8","author":"A Shumilov","year":"2017","unstructured":"Shumilov A et al (2017) Epstein-Barr virus particles induce centrosome amplification and chromosomal instability. Nat Commun 8:14257. https:\/\/doi.org\/10.1038\/ncomms14257","journal-title":"Nat Commun"},{"key":"1940_CR72","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1002\/ijc.24179","volume":"124","author":"CY Fang","year":"2009","unstructured":"Fang CY et al (2009) Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells. Int J Cancer 124:2016\u20132025. https:\/\/doi.org\/10.1002\/ijc.24179","journal-title":"Int J Cancer"},{"key":"1940_CR73","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/labinvest.2015.69","volume":"95","author":"J Yang","year":"2015","unstructured":"Yang J et al (2015) Epstein-Barr virus BZLF1 protein impairs accumulation of host DNA damage proteins at damage sites in response to DNA damage. Lab Invest 95:937\u2013950. https:\/\/doi.org\/10.1038\/labinvest.2015.69","journal-title":"Lab Invest"},{"key":"1940_CR74","doi-asserted-by":"publisher","first-page":"78948","DOI":"10.18632\/oncotarget.20695","volume":"8","author":"SY Huang","year":"2017","unstructured":"Huang SY et al (2017) Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells. Oncotarget 8:78948\u201378964. https:\/\/doi.org\/10.18632\/oncotarget.20695","journal-title":"Oncotarget"},{"key":"1940_CR75","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1093\/nar\/gkp1169","volume":"38","author":"CC Wu","year":"2010","unstructured":"Wu CC et al (2010) Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells. Nucleic Acids Res 38:1932\u20131949. https:\/\/doi.org\/10.1093\/nar\/gkp1169","journal-title":"Nucleic Acids Res"},{"key":"1940_CR76","doi-asserted-by":"publisher","first-page":"8583","DOI":"10.18632\/oncotarget.2323","volume":"5","author":"SH Chiu","year":"2014","unstructured":"Chiu SH et al (2014) Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma. Oncotarget 5:8583\u20138601. https:\/\/doi.org\/10.18632\/oncotarget.2323","journal-title":"Oncotarget"},{"key":"1940_CR77","doi-asserted-by":"publisher","first-page":"5583400","DOI":"10.1155\/2021\/5583400","volume":"2021","author":"J Jiang","year":"2021","unstructured":"Jiang J, Xu H, Wang Y, Lu H (2021) Identification and validation of autophagy-related gene nomograms to predict the prognostic value of patients with cervical cancer. J Oncol 2021:5583400. https:\/\/doi.org\/10.1155\/2021\/5583400","journal-title":"J Oncol"},{"key":"1940_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062981","author":"A Chmurska","year":"2021","unstructured":"Chmurska A, Matczak K, Marczak A (2021) Two Faces of Autophagy in the Struggle against Cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22062981","journal-title":"Int J Mol Sci"},{"key":"1940_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10050655","author":"JE Kim","year":"2021","unstructured":"Kim JE, Kang TC (2021) CDDO-me attenuates astroglial autophagy via Nrf2-, ERK1\/2-SP1- and Src-CK2-PTEN-PI3K\/AKT-mediated signaling pathways in the hippocampus of chronic epilepsy rats. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10050655","journal-title":"Antioxidants"},{"key":"1940_CR80","doi-asserted-by":"publisher","first-page":"12715","DOI":"10.1128\/jvi.02199-14","volume":"88","author":"M Granato","year":"2014","unstructured":"Granato M et al (2014) Epstein-barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication. J Virol 88:12715\u201312726. https:\/\/doi.org\/10.1128\/jvi.02199-14","journal-title":"J Virol"},{"key":"1940_CR81","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1080\/15548627.2020.1758416","volume":"17","author":"G Vilmen","year":"2021","unstructured":"Vilmen G et al (2021) BHRF1, a BCL2 viral homolog, disturbs mitochondrial dynamics and stimulates mitophagy to dampen type I IFN induction. Autophagy 17:1296\u20131315. https:\/\/doi.org\/10.1080\/15548627.2020.1758416","journal-title":"Autophagy"},{"key":"1940_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/v11121099","author":"Z Shao","year":"2019","unstructured":"Shao Z, Borde C, Quignon F, Escargueil A, Mar\u00e9chal V (2019) Epstein-Barr virus BALF0 and BALF1 modulate autophagy. Viruses. https:\/\/doi.org\/10.3390\/v11121099","journal-title":"Viruses"},{"key":"1940_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051158","author":"S Song","year":"2020","unstructured":"Song S et al (2020) BHRF1 enhances EBV mediated nasopharyngeal carcinoma tumorigenesis through modulating mitophagy associated with mitochondrial membrane permeabilization transition. Cells. https:\/\/doi.org\/10.3390\/cells9051158","journal-title":"Cells"},{"key":"1940_CR84","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1128\/jvi.74.16.7391-7399.2000","volume":"74","author":"J Lu","year":"2000","unstructured":"Lu J et al (2000) Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta. J Virol 74:7391\u20137399. https:\/\/doi.org\/10.1128\/jvi.74.16.7391-7399.2000","journal-title":"J Virol"},{"key":"1940_CR85","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.7150\/thno.73630","volume":"12","author":"J Hu","year":"2022","unstructured":"Hu J et al (2022) Erratum: Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum. Theranostics 12:3609. https:\/\/doi.org\/10.7150\/thno.73630","journal-title":"Theranostics"},{"key":"1940_CR86","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1128\/aac.03957-14","volume":"58","author":"N Coen","year":"2014","unstructured":"Coen N, Duraffour S, Topalis D, Snoeck R, Andrei G (2014) Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses. Antimicrob Agents Chemother 58:7312\u20137323. https:\/\/doi.org\/10.1128\/aac.03957-14","journal-title":"Antimicrob Agents Chemother"},{"key":"1940_CR87","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1128\/jvi.02659-10","volume":"85","author":"D Daigle","year":"2011","unstructured":"Daigle D et al (2011) Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle. J Virol 85:5628\u20135643. https:\/\/doi.org\/10.1128\/jvi.02659-10","journal-title":"J Virol"},{"key":"1940_CR88","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1128\/jvi.03505-12","volume":"87","author":"CB Whitehurst","year":"2013","unstructured":"Whitehurst CB et al (2013) Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase. J Virol 87:5311\u20135315. https:\/\/doi.org\/10.1128\/jvi.03505-12","journal-title":"J Virol"},{"key":"1940_CR89","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1743-422x-11-110","volume":"11","author":"AL Adamson","year":"2014","unstructured":"Adamson AL, Le BT, Siedenburg BD (2014) Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner. Virol J 11:110. https:\/\/doi.org\/10.1186\/1743-422x-11-110","journal-title":"Virol J"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-022-01940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-022-01940-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-022-01940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T10:15:48Z","timestamp":1673345748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-022-01940-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1940"],"URL":"https:\/\/doi.org\/10.1007\/s11262-022-01940-6","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"type":"print","value":"0920-8569"},{"type":"electronic","value":"1572-994X"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"assertion":[{"value":"24 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and\/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}